Showing results (41-50 of 718) with videos related to
Sort By:
Pageof 72
Current Drug Targets|June 22, 2006
Proteases and their role in chronic inflammatory lung diseasesFrank Bühling, David Groneberg, Tobias WelteTherapeutic Advances in Respiratory Disease|July 28, 2010
Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiencyThomas Köhnlein, Sabina Janciauskiene, Tobias WelteCurrent Opinion in Infectious Diseases|January 18, 2012
Is healthcare-associated pneumonia a distinct entity needing specific therapy?Santiago Ewig, Tobias Welte, Antoni TorresExpert Opinion on Pharmacotherapy|January 30, 2007
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practiceOlaf Burkhardt, Hartmut Derendorf, Tobias WelteTanaffos|September 6, 2014
Sample survey of chronic obstructive pulmonary disease and associated risk factors in isfahan, iranMohammad Golshan, Babak Amra, Tobias WelteMethods in Molecular Biology (Clifton, N.J.)|December 18, 2023
An Enzyme-Linked Immunosorbent Assay (ELISA) for Quantification of Circulating Pi*Z Alpha1-Antitrypsin PolymersSabina Janciauskiene, Tobias Welte, Matthias LehmannChest|October 21, 2021
Chest Infections After Lung TransplantationOana Joean, Tobias Welte, Jens GottliebDeutsche Medizinische Wochenschrift (1946)|June 26, 2023
[An outline of pulmonary hemorrhage - A pulmonologists perspective]Jannik Ruwisch, Tobias Welte, Antje PrassePneumologie (Stuttgart, Germany)|August 12, 2025
Staphylococcal pneumonia associated with Panton-Valentine leucocidin (PVL) toxinAdrian Gillissen, Daniel Räpple, Tina Wagenknecht, et al.Healthcare (Basel, Switzerland)|April 23, 2022
Medical Students' Perceptions towards Digitization and Artificial Intelligence: A Mixed-Methods StudyAdrian Gillissen, Tonja Kochanek, Michaela Zupanic, et al.Pageof 72